scholarly article | Q13442814 |
P50 | author | Thomas Unger | Q65602952 |
P2093 | author name string | Steffen Sandmann | |
Roland Schauer | |||
Freerk Prenzel | |||
Lee Shaw | |||
P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
Autolysis of human erythrocyte calpain produces two active enzyme forms with different cell localization | Q28115480 | ||
Calpain: novel family members, activation, and physiologic function | Q28273311 | ||
Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor | Q28346501 | ||
Calcium signaling | Q29618093 | ||
Contribution of Calcium-activated Neutral Protease to the Degradation Process of Ischemic Heart | Q36816289 | ||
Calcium-activated neutral protease (calpain) system: structure, function, and regulation | Q37767409 | ||
Calcium entry in the calcium paradox | Q40127225 | ||
Calpain: new perspectives in molecular diversity and physiological-pathological involvement. | Q40694801 | ||
An improved purification procedure for calpastatin, the inhibitor protein specific for the intracellular calcium-dependent proteinases, calpains | Q41300842 | ||
Simultaneous measurements of action potential duration and intracellular ATP in isolated ferret hearts exposed to cyanide | Q41349728 | ||
Calpain inhibitor I reduces the development of acute and chronic inflammation | Q41761302 | ||
The effects of truncations of the small subunit on m-calpain activity and heterodimer formation | Q41811321 | ||
Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart | Q42483382 | ||
Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart | Q42511977 | ||
Cytoskeletal damage during myocardial ischemia: changes in vinculin immunofluorescence staining during total in vitro ischemia in canine heart | Q44926546 | ||
Reduction of experimentally produced acute myocardial infarction size by a new synthetic inhibitor, NCO-700, against calcium-activated neutral protease | Q47265304 | ||
Proteolysis of tubulin and microtubule-associated proteins 1 and 2 by calpain I and II. Difference in sensitivity of assembled and disassembled microtubules. | Q48120501 | ||
In vitro proteolysis of brain spectrin by calpain I inhibits association of spectrin with ankyrin-independent membrane binding site(s) | Q48653859 | ||
Dynamic changes in sarcoplasmic reticulum function in cardiac hypertrophy and failure. | Q52082514 | ||
Reperfusion of Rat Heart After Brief Ischemia Induces Proteolysis of Calspectin (Nonerythroid Spectrin or Fodrin) by Calpain | Q52508970 | ||
Reperfusion after brief ischemia disrupts the microtubule network in canine hearts. | Q52517210 | ||
Calcium - a life and death signal | Q56836038 | ||
Autolysis, Ca2+Requirement, and Heterodimer Stability in m-Calpain | Q62001103 | ||
Activation of calpain I and hydrolysis of calpain substrates (actin-binding protein, glycoprotein Ib, and talin) are not a function of thrombin-induced platelet aggregation | Q67991788 | ||
Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat | Q68409187 | ||
Calcium-activated neutral protease inhibitor (E-64c) and reperfusion for experimental myocardial infarction | Q69357413 | ||
Altered calcium handling in experimental pressure-overload hypertrophy in the ferret | Q69979818 | ||
Purification and characterization of two distinct Ca2+-activated proteinases from hearts of hypertensive rats | Q70095707 | ||
Canine cardiac calcium-dependent proteases: Resolution of two forms with different requirements for calcium | Q71493339 | ||
The calpain cascade. Mu-calpain activates m-calpain | Q71903310 | ||
Calpain is implicated in rat myocardial injury after ischemia or reperfusion | Q72242065 | ||
Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates | Q72397802 | ||
A catalytic subunit of calpain possesses full proteolytic activity | Q72408908 | ||
Calpain dissociates into subunits in the presence of calcium ions | Q72625097 | ||
Effects of thiol protease inhibitors on fodrin degradation during hypoxia in cultured myocytes | Q72712962 | ||
Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis | Q73108727 | ||
Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats | Q73311814 | ||
A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy | Q73957891 | ||
Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies | Q74615255 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1951-1958 | |
P577 | publication date | 2002-04-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Activity profile of calpains I and II in chronically infarcted rat myocardium--influence of the calpain inhibitor CAL 9961. | |
P478 | volume | 135 |
Q34247022 | A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss. |
Q37990195 | All cut up! The consequences of calpain activation on platelet function |
Q37431011 | Calpain inhibition preserves myocardial structure and function following myocardial infarction. |
Q48725567 | Calpain inhibitor MDL 28170 protects against the Ca2+ paradox in rat hearts |
Q39004902 | Calpain research for drug discovery: challenges and potential |
Q38234563 | Calpain system and its involvement in myocardial ischemia and reperfusion injury |
Q42732431 | Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling |
Q55022904 | Effect of Target Therapy on the Content of Transcription and Growth Factors, Protein Kinase TOR, and Activity of Intracellular Proteases in Patients with Metastatic Renal Cell Carcinoma. |
Q92404333 | Expression of calcineurin, calpastatin and heat shock proteins during ischemia and reperfusion |
Q85793510 | Expression of vascular endothelial growth factor and transcription factors HIF-1, NF-kB expression in squamous cell carcinoma of head and neck; association with proteasome and calpain activities |
Q38010378 | High molecular weight calmodulin-binding protein: 20 years onwards-a potential therapeutic calpain inhibitor |
Q58769134 | Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer's disease mice and correlates with memory deficits in human subjects |
Q37812402 | Physiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation |
Q35201401 | Protective effect of calpain inhibitor N-acetyl-L-leucyl-L-leucyl-L-norleucinal on acute alcohol consumption related cardiomyopathy |
Q34168662 | Receptor-Independent Cardiac Protein Kinase Cα Activation by Calpain-Mediated Truncation of Regulatory Domains |
Q58698801 | Targeting Calpain for Heart Failure Therapy: Implications From Multiple Murine Models |
Q35151516 | Tear me down: role of calpain in the development of cardiac ventricular hypertrophy |
Q40616132 | The calpain 1-alpha-actinin interaction. Resting complex between the calcium-dependent protease and its target in cytoskeleton |
Q37798968 | The role of calpain in diabetes-associated platelet hyperactivation. |
Q99399885 | Under construction: The dynamic assembly, maintenance, and degradation of the cardiac sarcomere |
Search more.